Company press releases

Displaying 1 - 50 of 106 results
Released Company Title Industry Topic
09 Dec 2024
20:17 CET 		EUROAPI SA EUROAPI entame un nouveau chapitre avec une nouvelle gouvernance et un nouveau management 20103015 Pharmaceuticals Other subject
09 Dec 2024
20:17 CET 		EUROAPI SA EUROAPI moves into a new chapter with new Governance and Leadership  20103015 Pharmaceuticals Other subject
16 Oct 2024
07:00 CEST 		EUROAPI SA Olivier Falut est nommé Directeur financier d’EUROAPI 20103015 Pharmaceuticals Other subject
16 Oct 2024
07:00 CEST 		EUROAPI SA Olivier Falut appointed EUROAPI’s Chief Financial Officer 20103015 Pharmaceuticals Other subject
15 Oct 2024
17:45 CEST 		EUROAPI SA EUROAPI clôt le financement de son plan FOCUS-27 20103015 Pharmaceuticals Other subject
15 Oct 2024
17:45 CEST 		EUROAPI SA EUROAPI closes the financing of its FOCUS-27 plan 20103015 Pharmaceuticals Other subject
10 Oct 2024
20:38 CEST 		EUROAPI SA EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution 20103015 Pharmaceuticals Other subject
10 Oct 2024
20:38 CEST 		EUROAPI SA EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution 20103015 Pharmaceuticals Other subject
05 Aug 2024
08:00 CEST 		EUROAPI SA EUROAPI - Availability of 2024 Half-Year Financial Report 20103015 Pharmaceuticals Income
05 Aug 2024
08:00 CEST 		EUROAPI SA EUROAPI - Mise à disposition du Rapport financier semestriel 2024 20103015 Pharmaceuticals Income
30 Jul 2024
17:45 CEST 		EUROAPI SA H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap 20103015 Pharmaceuticals Other subject
30 Jul 2024
17:45 CEST 		EUROAPI SA RESULTATS DU PREMIER SEMESTRE 2024 - Le plan stratégique Focus-27 est en bonne voie avec une exécution dans les délais de la feuille de route opérationnelle 20103015 Pharmaceuticals Other subject
26 Jun 2024
17:40 CEST 		EUROAPI SA EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1 20103015 Pharmaceuticals Other subject
26 Jun 2024
17:40 CEST 		EUROAPI SA EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1 20103015 Pharmaceuticals Other subject
18 Jun 2024
07:00 CEST 		EUROAPI SA EUROAPI and Priothera enter into CDMO collaboration to advance oncology project 20103015 Pharmaceuticals Other subject
18 Jun 2024
07:00 CEST 		EUROAPI SA EUROAPI et Priothera signent un accord de CDMO pour un projet en oncologie 20103015 Pharmaceuticals Other subject
06 Jun 2024
17:53 CEST 		EUROAPI SA Information marché  Financement du projet de transformation FOCUS-27 20103015 Pharmaceuticals Other subject
06 Jun 2024
17:53 CEST 		EUROAPI SA Market update : FOCUS-27 transformation project financing 20103015 Pharmaceuticals Other subject
06 Jun 2024
07:00 CEST 		EUROAPI SA EUROAPI franchit une étape majeure du PIIEC Santé avec la notification officielle de la Commission européenne 20103015 Pharmaceuticals Other subject
06 Jun 2024
07:00 CEST 		EUROAPI SA EUROAPI reaches major Health IPCEI milestone with official notification from European Commission 20103015 Pharmaceuticals Other subject
23 May 2024
07:00 CEST 		EUROAPI SA EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros 20103015 Pharmaceuticals Other subject
23 May 2024
07:00 CEST 		EUROAPI SA EUROAPI strengthens its presence in animal health with a €130-150 million supply contract 20103015 Pharmaceuticals Other subject
22 May 2024
17:45 CEST 		EUROAPI SA Combined General Meeting of May 22, 2024 20103015 Pharmaceuticals Other subject
22 May 2024
17:45 CEST 		EUROAPI SA Assemblée Générale Mixte du 22 mai 2024 20103015 Pharmaceuticals Other subject
13 May 2024
18:00 CEST 		EUROAPI SA Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer 20103015 Pharmaceuticals Other subject
13 May 2024
18:00 CEST 		EUROAPI SA Evelyne Nguyen est nommée Directrice financière d’EUROAPI 20103015 Pharmaceuticals Other subject
30 Apr 2024
07:00 CEST 		EUROAPI SA Combined General Meeting of May 22, 2024 - Availability of preparatory documents 20103015 Pharmaceuticals Other subject
30 Apr 2024
07:00 CEST 		EUROAPI SA Assemblée Générale mixte du 22 mai 2024 - Modalités de mise à disposition ou de consultation des documents préparatoires 20103015 Pharmaceuticals Other subject
09 Apr 2024
18:18 CEST 		EUROAPI SA EUROAPI streamlines its Executive Committee to improve focus and efficiency 20103015 Pharmaceuticals Other subject
09 Apr 2024
18:18 CEST 		EUROAPI SA EUROAPI resserre son Comité exécutif afin de se recentrer et de gagner en efficacité 20103015 Pharmaceuticals Other subject
05 Apr 2024
18:20 CEST 		EUROAPI SA Availability of the 2023 Universal Registration Document, including the Annual Financial Report 20103015 Pharmaceuticals Other subject
05 Apr 2024
18:20 CEST 		EUROAPI SA Mise à disposition du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel 20103015 Pharmaceuticals Other subject
28 Mar 2024
07:00 CET 		EUROAPI SA Document d’Enregistrement Universel 2023 20103015 Pharmaceuticals Other subject
28 Mar 2024
07:00 CET 		EUROAPI SA 2023 Universal Registration Document 20103015 Pharmaceuticals Other subject
14 Mar 2024
18:55 CET 		EUROAPI SA Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie 20103015 Pharmaceuticals Other subject
14 Mar 2024
18:55 CET 		EUROAPI SA Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy 20103015 Pharmaceuticals Other subject
28 Feb 2024
19:16 CET 		EUROAPI SA Résultats annuels 2023 20103015 Pharmaceuticals Other subject
28 Feb 2024
19:16 CET 		EUROAPI SA Full-year 2023 results 20103015 Pharmaceuticals Other subject
25 Jan 2024
07:00 CET 		EUROAPI SA EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO) 20103015 Pharmaceuticals Other subject
25 Jan 2024
07:00 CET 		EUROAPI SA EUROAPI enrichit ses compétences en CDMO grâce à une collaboration essentielle avec SpiroChem, une Contract Research Organization (CRO) de premier plan 20103015 Pharmaceuticals Other subject
04 Jan 2024
17:45 CET 		EUROAPI SA EUROAPI renforce son Comité Exécutif en nommant Ludwig de Mot Directeur Général Adjoint, en charge de la transformation de l’entreprise 20103015 Pharmaceuticals Other subject
04 Jan 2024
17:45 CET 		EUROAPI SA EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer 20103015 Pharmaceuticals Other subject
28 Nov 2023
08:00 CET 		EUROAPI SA EUROAPI Appoints New Executive Committee Members 20103015 Pharmaceuticals Other subject
28 Nov 2023
08:00 CET 		EUROAPI SA EUROAPI nomme de nouveaux membres au Comité Exécutif 20103015 Pharmaceuticals Other subject
21 Nov 2023
17:45 CET 		EUROAPI SA CDMO : EUROAPI finalise l’acquisition de Biano 20103015 Pharmaceuticals Other subject
21 Nov 2023
17:45 CET 		EUROAPI SA CDMO: EUROAPI Completes Acquisition of Biano 20103015 Pharmaceuticals Other subject
30 Oct 2023
18:38 CET 		EUROAPI SA EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer 20103015 Pharmaceuticals Other subject
30 Oct 2023
18:38 CET 		EUROAPI SA EUROAPI : Information relative aux conditions financières du départ du Directeur Général et de la nomination de la Présidente du Conseil d’Administration comme Directrice Générale par intérim 20103015 Pharmaceuticals Other subject
25 Oct 2023
18:15 CEST 		EUROAPI SA Nouvelle gouvernance chez EUROAPI 20103015 Pharmaceuticals Other subject
25 Oct 2023
18:15 CEST 		EUROAPI SA EUROAPI Announces New Governance 20103015 Pharmaceuticals Other subject